RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Pioneering research led by the University of Bristol has repurposed a gene-editing tool to help shed light on the true ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.

ToolGen, Inc. (KOSDAQ 199800), led by CEO Jong Sang Ryu and recognized as a global leader in genome editing technology, announced today that it has filed a patent infringement lawsuit in the United ...

Abu Dhabi Global Health Week today honoured exceptional individuals and institutions from around the world whose innovative ...

Abu Dhabi Global Health Week (ADGHW) today honoured exceptional individuals and institutions from around the world whose ...

The 2006 paper `Using thematic analysis in psychology’ has been cited between 100,000 and 230,000 times, based on a range of ...

A Nature analysis reveals the 25 highest-cited papers published this century and explores why they are breaking records.